Brigitte Keller‐Stanislawski

2.4k total citations
91 papers, 1.6k citations indexed

About

Brigitte Keller‐Stanislawski is a scholar working on Infectious Diseases, Epidemiology and Health. According to data from OpenAlex, Brigitte Keller‐Stanislawski has authored 91 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 16 papers in Epidemiology and 13 papers in Health. Recurrent topics in Brigitte Keller‐Stanislawski's work include SARS-CoV-2 and COVID-19 Research (13 papers), Vaccine Coverage and Hesitancy (13 papers) and Blood transfusion and management (11 papers). Brigitte Keller‐Stanislawski is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (13 papers), Vaccine Coverage and Hesitancy (13 papers) and Blood transfusion and management (11 papers). Brigitte Keller‐Stanislawski collaborates with scholars based in Germany, United Kingdom and United States. Brigitte Keller‐Stanislawski's co-authors include Markus B. Funk, Angelika Reil, M. Heiden, Doris Oberle, Jürgen Bux, A. Lohmann, Dirk Mentzer, Punam Mangtani, Karin Weißer and Michael Chudy and has published in prestigious journals such as Neurology, Journal of Neurology Neurosurgery & Psychiatry and SLEEP.

In The Last Decade

Brigitte Keller‐Stanislawski

84 papers receiving 1.5k citations

Peers

Brigitte Keller‐Stanislawski
Mars Stone United States
Sridhar V. Basavaraju United States
W. James Alexander United States
Ali Danesh United States
Mars Stone United States
Brigitte Keller‐Stanislawski
Citations per year, relative to Brigitte Keller‐Stanislawski Brigitte Keller‐Stanislawski (= 1×) peers Mars Stone

Countries citing papers authored by Brigitte Keller‐Stanislawski

Since Specialization
Citations

This map shows the geographic impact of Brigitte Keller‐Stanislawski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brigitte Keller‐Stanislawski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brigitte Keller‐Stanislawski more than expected).

Fields of papers citing papers by Brigitte Keller‐Stanislawski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brigitte Keller‐Stanislawski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brigitte Keller‐Stanislawski. The network helps show where Brigitte Keller‐Stanislawski may publish in the future.

Co-authorship network of co-authors of Brigitte Keller‐Stanislawski

This figure shows the co-authorship network connecting the top 25 collaborators of Brigitte Keller‐Stanislawski. A scholar is included among the top collaborators of Brigitte Keller‐Stanislawski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brigitte Keller‐Stanislawski. Brigitte Keller‐Stanislawski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Padberg, Stephanie, Brigitte Keller‐Stanislawski, Doris Oberle, et al.. (2025). First trimester mRNA COVID-19 vaccination and risk of congenital malformation: a prospective observational Embryotox cohort study. Clinical Microbiology and Infection. 31(9). 1571–1578.
2.
Peinemann, Frank, et al.. (2024). Adverse Menstrual Events Reported After and Before (or Without) COVID‐19 Vaccination: A Systematic Review and Meta‐Analysis of Comparative Observational Studies. Pharmacoepidemiology and Drug Safety. 33(8). e5877–e5877. 2 indexed citations
3.
Lehmann, Helmar C., et al.. (2023). Rare cases of Guillain-Barré syndrome after COVID-19 vaccination, Germany, December 2020 to August 2021. Eurosurveillance. 28(24). 2 indexed citations
4.
Bierbaum, Sibylle, Alexander Enk, Hartmut Hengel, et al.. (2023). Skin manifestations after immunisation with an adjuvanted recombinant zoster vaccine, Germany, 2020. Eurosurveillance. 28(50). 2 indexed citations
5.
Thiele, Thomas, Karin Weißer, Linda Schönborn, et al.. (2021). Laboratory confirmed vaccine-induced immune thrombotic thrombocytopenia: Retrospective analysis of reported cases after vaccination with ChAdOx-1 nCoV-19 in Germany. The Lancet Regional Health - Europe. 12. 100270–100270. 32 indexed citations
6.
Heiden, M., et al.. (2021). Blood Donation-Related Adverse Reactions: Results of an Online Survey among Donors in Germany (2018). Transfusion Medicine and Hemotherapy. 48(5). 272–283. 11 indexed citations
7.
Corman, Victor M., Holger F. Rabenau, Ortwin Adams, et al.. (2020). SARS‐CoV ‐2 asymptomatic and symptomatic patients and risk for transfusion transmission. Transfusion. 60(6). 1119–1122. 53 indexed citations
10.
Weißer, Karin, Thomas Göen, Jennifer D. Oduro, et al.. (2019). Aluminium in plasma and tissues after intramuscular injection of adjuvanted human vaccines in rats. Archives of Toxicology. 93(10). 2787–2796. 11 indexed citations
11.
Oberle, Doris, et al.. (2017). Spontaneous reporting of suspected narcolepsy after vaccination against pandemic influenza A (H1N1) in Germany. Pharmacoepidemiology and Drug Safety. 26(11). 1321–1327. 2 indexed citations
13.
Wiedermann, Ursula, Herwig Kollaritsch, Heidemarie Holzmann, et al.. (2014). Reaktionen und Nebenwirkungen nach Impfungen: Erläuterungen und Definitionen in Ergänzung zum Österreichischen Impfplan. 2(1). e2–e2.
14.
Oppermann, Marc, Juliane Fritzsche, Corinna Weber‐Schoendorfer, et al.. (2012). A(H1N1)v2009: A controlled observational prospective cohort study on vaccine safety in pregnancy. Vaccine. 30(30). 4445–4452. 66 indexed citations
15.
Hartung, Hans‐Peter, Brigitte Keller‐Stanislawski, Richard AC Hughes, & Helmar C. Lehmann. (2012). Guillain-Barré-Syndrom nach Exposition mit Influenza. Der Nervenarzt. 83(6). 714–730. 7 indexed citations
16.
Spiczak, Sarah von, Ingo Helbig, Hiltrud Muhle, et al.. (2011). A retrospective population‐based study on seizures related to childhood vaccination. Epilepsia. 52(8). 1506–1512. 19 indexed citations
17.
Funk, Markus B., et al.. (2011). Transfusion-Transmitted Bacterial Infections – Haemovigilance Data of German Blood Establishments (1997–2010). Transfusion Medicine and Hemotherapy. 38(4). 266–271. 36 indexed citations
18.
Keller‐Stanislawski, Brigitte, et al.. (2009). Frequency and severity of transfusion-related acute lung injury â German haemovigilance data (2006â2007). Vox Sanguinis. 98(1). 70–77. 65 indexed citations
19.
Pfleiderer, Michael, et al.. (2008). Vaccination Safety Update. Deutsches Ärzteblatt international. 105(34-35). 590–5. 4 indexed citations
20.
Hartmann, Katrin & Brigitte Keller‐Stanislawski. (2002). Rekombinante Hepatitis-B-Impfstoffe und Verdachtsfälle unerwünschter Reaktionen Eine Bewertung der Spontanerfassungsdaten des Paul-Ehrlich-Instituts 1995 bis 2000. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 45(4). 355–363. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026